Search Within

Michael Andrew Postow

Formats
  1. Journal Article (191)
  2. Meeting Abstract (137)
  3. Editorial (9)
  4. Review (9)
  5. Book Section (4)
  6. Guidelines (4)
  7. Research Letter (4)
  8. Miscellaneous (2)
  9. Book Whole (1)
  10. Correspondence (1)
Groups
  1. Department of Medicine (362)
  2. Melanoma Disease Management Team (362)
  3. Melanoma and Immunotherapeutics Service (362)
  4. Solid Tumor Oncology Division (362)
  5. GSK Faculty (178)
  6. Hematologic Malignancies, Division of (103)

More Groups

People
  1. Jedd Wolchok (158)
  2. Margaret Callahan (95)
  3. Katherine Panageas (64)
  4. Alexander Shoushtari (63)
  5. Paul Chapman (54)
  6. Parisa Momtaz (36)

More People

Years
  1. 2025 (16)
  2. 2024 (19)
  3. 2023 (23)
  4. 2022 (23)
  5. 2021 (27)
  6. 2020 (30)

More Years

Publications
  1. Journal of Clinical Oncology (90)
  2. Journal for ImmunoTherapy of Cancer (34)
  3. Clinical Cancer Research (16)
  4. Annals of Oncology (13)
  5. International Journal of Radiation Oncology, Biology, Physics (12)
  6. The Oncologist (12)

More Publications

Publishers
  1. American Society of Clinical Oncology (92)
  2. Biomed Central Ltd (43)
  3. Oxford University Press (32)
  4. Elsevier Inc. (31)
  5. American Association for Cancer Research (24)
  6. Wiley Blackwell (21)

More Publishers

Results (362)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis
    Journal Article

    Badran, Y. R.; Zou, F.; Durbin, S. M.; Dutra, B. E.; Abu-Sbeih, H.; Thomas, A. S.; Altan, M.; Thompson, J. A.; Qiao, W.; Leet, D. E.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Eganelisib, a first-in-class PI3Kγ inhibitor, in patients with advanced solid tumors: Results of the phase 1/1b MARIO-1 trial
    Journal Article

    Hong, D. S.; Postow, M.; Chmielowski, B.; Sullivan, R.; Patnaik, A.; Cohen, E. E. W.; Shapiro, G.; Steuer, C.; Gutierrez, M.; Yeckes-Rodin, H.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Autoantibody biomarkers of immune-related adverse events and survival in melanoma patients receiving immune checkpoint inhibitor therapy
    Meeting Abstract

    Aude, C.; Ghosh, N.; Jannat-Khah, D.; Chan, K. K.; Postow, M.; Larman, H.; Bass, A.
    Annals of the Rheumatic Diseases (2023)

    Fulltext@MSK | Save
  • CD38HI cytotoxic CD8 T cells are expanded following checkpoint blockade and characterize the T cell infiltrate in checkpoint inhibitor-associated arthritis
    Meeting Abstract

    Singaraju, A.; Marks, K. E.; Wang, R.; Shakib, L.; Dunlap, G.; Cunningham-Bussel, A.; Greisen, S. R.; Chen, L.; Tirpack, A.; Fein, M.; more...
    Annals of the Rheumatic Diseases (2023)

    Fulltext@MSK | Save
  • Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1
    Journal Article

    Loo, K.; Kalvin, H. L.; Panageas, K. S.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; Postow, M. A.; Warner, A. B.
    Pigment Cell & Melanoma Research (2023)

    Fulltext@MSK | Save
  • Decision-making and health-related quality of life in patients with melanoma considering adjuvant immunotherapy
    Journal Article

    Atkinson, T. M.; Hay, J. L.; Kim, S. Y.; Schofield, E.; Postow, M. A.; Momtaz, P.; Warner, A. B.; Shoushtari, A. N.; Callahan, M. K.; Wolchok, J. D.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Efficacy of immunotherapy for melanoma brain metastases in patients with concurrent corticosteroid exposure
    Journal Article

    Tringale, K. R.; Reiner, A. S.; Sehgal, R. R.; Panageas, K.; Warner, A. S. B.; Postow, M. A.; Moss, N. S.
    CNS Oncology (2023)

    Fulltext@MSK | Save
  • Associations between race/ethnicity, language, and enrollment on cancer research studies
    Journal Article

    Ezeoke, O. M.; Brooks, G.; Postow, M. A.; Baxi, S.; Kim, S. Y.; Narang, B.; Diamond, L. C.
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Assessing the correlation between CD8 cell PET imaging with 89-ZR-crefmirlimab berdoxam and CD8 cell immunohistochemistry in patients with advanced cancer receiving immunotherapy
    Meeting Abstract

    Postow, M.; Mauguen, A.; Farwell, M.; Gordon, M.; Hays, D.; Wong, J.; Pal, S.; Chen, D.; Ulaner, G.; McConathy, J.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Comparative safety and effectiveness of IL6R inhibitors, TNF inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis
    Meeting Abstract

    Bass, A.; Abdel-Wahab, N.; Sparks, J.; Reid, P.; Calabrese, C.; Jannat-Khah, D.; Rajesh, D.; Ghosh, N.; Mushtak, K.; Al Haj, F.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save